These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 30968592)

  • 1. Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2.
    Pauleikhoff D; Bonelli R; Dubis AM; Gunnemann F; Rothaus K; Charbel Issa P; Heeren TF; Peto T; Clemons TE; Chew EY; Bird AC; Sallo FB;
    Acta Ophthalmol; 2019 Nov; 97(7):e998-e1005. PubMed ID: 30968592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography.
    Pauleikhoff D; Gunnemann F; Book M; Rothaus K
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1381-1392. PubMed ID: 31093765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OCT Angiography and Ellipsoid Zone Mapping of Macular Telangiectasia Type 2 From the AVATAR Study.
    Runkle AP; Kaiser PK; Srivastava SK; Schachat AP; Reese JL; Ehlers JP
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3683-3689. PubMed ID: 28727884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OCT of Outer Retinal Hyperreflectivity, Neovascularization, and Pigment in Macular Telangiectasia Type 2.
    Krivosic V; Lavia C; Aubineau A; Tadayoni R; Gaudric A
    Ophthalmol Retina; 2021 Jun; 5(6):562-570. PubMed ID: 32956858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CORRELATION OF CLINICAL AND STRUCTURAL PROGRESSION WITH VISUAL ACUITY LOSS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 6-The MacTel Research Group.
    Peto T; Heeren TFC; Clemons TE; Sallo FB; Leung I; Chew EY; Bird AC
    Retina; 2018 Jan; 38 Suppl 1(Suppl 1):S8-S13. PubMed ID: 28505012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.
    Ayachit AG; Reddy LU; Joshi S; Ayachit GS
    Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LONGITUDINAL CORRELATION OF ELLIPSOID ZONE LOSS AND FUNCTIONAL LOSS IN MACULAR TELANGIECTASIA TYPE 2.
    Heeren TFC; Kitka D; Florea D; Clemons TE; Chew EY; Bird AC; Pauleikhoff D; Charbel Issa P; Holz FG; Peto T
    Retina; 2018 Jan; 38 Suppl 1(Suppl 1):S20-S26. PubMed ID: 28541959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of spectral-domain optical coherence tomography features in assessment of visual prognosis in eyes with acute welding arc maculopathy.
    Zhang C; Dang G; Zhao T; Wang D; Su Y; Qu Y
    Int Ophthalmol; 2019 May; 39(5):1081-1088. PubMed ID: 29651692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MACULAR TELANGIECTASIA TYPE 2: Acircularity Index and Quantitative Assessment of Foveal Avascular Zone Using Optical Coherence Tomography Angiography.
    Ersoz MG; Hocaoglu M; Sayman Muslubas I; Arf S; Karacorlu M
    Retina; 2020 Jun; 40(6):1132-1139. PubMed ID: 30893277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying the Rate of Ellipsoid Zone Loss in Stargardt Disease.
    Cai CX; Light JG; Handa JT
    Am J Ophthalmol; 2018 Feb; 186():1-9. PubMed ID: 29126757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation Between Macular Integrity Assessment and Optical Coherence Tomography Imaging of Ellipsoid Zone in Macular Telangiectasia Type 2.
    Mukherjee D; Lad EM; Vann RR; Jaffe SJ; Clemons TE; Friedlander M; Chew EY; Jaffe GJ; Farsiu S;
    Invest Ophthalmol Vis Sci; 2017 May; 58(6):BIO291-BIO299. PubMed ID: 28973315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical coherence tomography-angiography for monitoring neovascularisations in macular telangiectasia type 2.
    Tzaridis S; Hess K; Friedlander M; Holz FG
    Br J Ophthalmol; 2021 May; 105(5):735-740. PubMed ID: 32513667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ELLIPSOID ZONE RECOVERY IN MACULAR TELANGIECTASIA TYPE 2.
    Goerdt L; Raming K; Rodriguez Garcia JL; Pfau K; Holz FG; Herrmann P
    Retina; 2024 Aug; 44(8):1413-1421. PubMed ID: 38513243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of interdigitation zone changes and right-angle vessels in Macular Telangiectasia Type-2 (MacTel).
    Chandran K; Giridhar A; Gopalakrishnan M; Sivaprasad S
    Eye (Lond); 2023 Oct; 37(14):2977-2986. PubMed ID: 36841866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macular Pigment Distribution as Prognostic Marker for Disease Progression in Macular Telangiectasia Type 2.
    Müller S; Charbel Issa P; Heeren TFC; Thiele S; Holz FG; Herrmann P
    Am J Ophthalmol; 2018 Oct; 194():163-169. PubMed ID: 30053477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-stage macular telangiectasia type 2 vascular abnormalities are associated with interdigitation zone disruption.
    Ong JX; Zandi R; Fawzi AA
    PLoS One; 2021; 16(11):e0259811. PubMed ID: 34767582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early deterioration in ellipsoid zone in eyes with non-neovascular age-related macular degeneration.
    Toprak I; Yaylalı V; Yildirim C
    Int Ophthalmol; 2017 Aug; 37(4):801-806. PubMed ID: 27591785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeleton density and ellipsoid zone loss are prognostic for progression in Macular Telangiectasia Type 2.
    Goerdt L; Berger M; Jungblut J; Rodriguez Garcia JL; Pfau K; Herrmann P; Holz FG; Wintergerst MWM
    Sci Rep; 2024 Jul; 14(1):17328. PubMed ID: 39068228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right-angled vessels in macular telangiectasia type 2.
    Tzaridis S; Heeren T; Mai C; Thiele S; Holz FG; Charbel Issa P; Herrmann P
    Br J Ophthalmol; 2021 Sep; 105(9):1289-1296. PubMed ID: 30808615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cystoid macular edema as a marker in the progression of non-paraneoplastic autoimmune retinopathy.
    Finn AP; Thomas AS; Stinnett SS; Keenan RT; Grewal DS; Jaffe GJ
    Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):1867-1873. PubMed ID: 30128606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.